Sosman JA - Search Results

1

Immunosuppressive IDO in Cancer: Mechanisms of Action, Animal Models, and Targeting Strategies.

Zhai L, Bell A, Ladomersky E, Lauing KL, Bollu L, Sosman JA, Zhang B, Wu JD, Miller SD, Meeks JJ, Lukas RV, Wyatt E, Doglio L, Schiltz GE, McCusker RH, Wainwright DA. Zhai L, et al. Among authors: sosman ja. Front Immunol. 2020 Jun 16;11:1185. doi: 10.3389/fimmu.2020.01185. eCollection 2020. Front Immunol. 2020. PMID: 32612606 Free PMC article. Review.

2

Cancer Immunotherapies: Are They as Effective in the Elderly?

Poropatich K, Fontanarosa J, Samant S, Sosman JA, Zhang B. Poropatich K, et al. Among authors: sosman ja. Drugs Aging. 2017 Aug;34(8):567-581. doi: 10.1007/s40266-017-0479-1. Drugs Aging. 2017. PMID: 28707274 Review.

3

Infiltrating T Cells Increase IDO1 Expression in Glioblastoma and Contribute to Decreased Patient Survival.

Zhai L, Ladomersky E, Lauing KL, Wu M, Genet M, Gritsina G, Győrffy B, Brastianos PK, Binder DC, Sosman JA, Giles FJ, James CD, Horbinski C, Stupp R, Wainwright DA. Zhai L, et al. Among authors: sosman ja. Clin Cancer Res. 2017 Nov 1;23(21):6650-6660. doi: 10.1158/1078-0432.CCR-17-0120. Epub 2017 Jul 27. Clin Cancer Res. 2017. PMID: 28751450 Free PMC article.

4

CD73 expression on effector T cells sustained by TGF-β facilitates tumor resistance to anti-4-1BB/CD137 therapy.

Chen S, Fan J, Zhang M, Qin L, Dominguez D, Long A, Wang G, Ma R, Li H, Zhang Y, Fang D, Sosman J, Zhang B. Chen S, et al. Nat Commun. 2019 Jan 11;10(1):150. doi: 10.1038/s41467-018-08123-8. Nat Commun. 2019. PMID: 30635578 Free PMC article.

5

The Coincidence Between Increasing Age, Immunosuppression, and the Incidence of Patients With Glioblastoma.

Ladomersky E, Scholtens DM, Kocherginsky M, Hibler EA, Bartom ET, Otto-Meyer S, Zhai L, Lauing KL, Choi J, Sosman JA, Wu JD, Zhang B, Lukas RV, Wainwright DA. Ladomersky E, et al. Among authors: sosman ja. Front Pharmacol. 2019 Mar 27;10:200. doi: 10.3389/fphar.2019.00200. eCollection 2019. Front Pharmacol. 2019. PMID: 30971917 Free PMC article.

6

Dermatomyositis in a patient undergoing nivolumab therapy for metastatic melanoma: a case report and review of the literature.

Kosche C, Stout M, Sosman J, Lukas RV, Choi JN. Kosche C, et al. Melanoma Res. 2020 Jun;30(3):313-316. doi: 10.1097/CMR.0000000000000642. Melanoma Res. 2020. PMID: 31567590 Review.

7

Past, Current, and Future of Immunotherapies for Prostate Cancer.

Boettcher AN, Usman A, Morgans A, VanderWeele DJ, Sosman J, Wu JD. Boettcher AN, et al. Front Oncol. 2019 Sep 11;9:884. doi: 10.3389/fonc.2019.00884. eCollection 2019. Front Oncol. 2019. PMID: 31572678 Free PMC article. Review.

8

Antibody targeting tumor-derived soluble NKG2D ligand sMIC reprograms NK cell homeostatic survival and function and enhances melanoma response to PDL1 blockade therapy.

Basher F, Dhar P, Wang X, Wainwright DA, Zhang B, Sosman J, Ji Z, Wu JD. Basher F, et al. J Hematol Oncol. 2020 Jun 9;13(1):74. doi: 10.1186/s13045-020-00896-0. J Hematol Oncol. 2020. PMID: 32517713 Free PMC article.

9

The Janus Face of IL-33 Signaling in Tumor Development and Immune Escape.

Choi MR, Sosman JA, Zhang B. Choi MR, et al. Among authors: sosman ja. Cancers (Basel). 2021 Jun 30;13(13):3281. doi: 10.3390/cancers13133281. Cancers (Basel). 2021. PMID: 34209038 Free PMC article. Review.

10

Leptomeningeal metastases: the future is now.

Lukas RV, Thakkar JP, Cristofanilli M, Chandra S, Sosman JA, Patel JD, Kumthekar P, Stupp R, Lesniak MS. Lukas RV, et al. Among authors: sosman ja. J Neurooncol. 2022 Feb;156(3):443-452. doi: 10.1007/s11060-021-03924-2. Epub 2022 Jan 20. J Neurooncol. 2022. PMID: 35048267 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

355 results

Search Page